HOME   
   NEWS   
   BUSINESS   
   CRICKET   
   SPORTS   
   MOVIES   
   NET GUIDE   
   SHOPPING   
   BLOGS  
   ASTROLOGY  
   MATCHMAKER  


Search:



The Web

Rediff








Business
Portfolio Tracker
Business News
Specials
Columns
Market Report
Mutual Funds
Interviews
Tutorials
Message Board
Stock Talk
Press Releases



Home > Business > Business Headline > Report

Reliance Life to shift to IPCL

Hemangi Balse in Mumbai | May 26, 2003 12:30 IST

Reliance Life Sciences is planning to set up its biotechnology-based production facilities at Indian Vaccines Corporation, a subsidiary of IPCL.

A joint venture of IPCL and the department of biotechnology, the Indian Vaccines Corporation was promoted for the commercial production of injectible polio vaccines in the country. However, the project did not take off.

The Reliance Group is in talks with the government to acquire management control at the corporation to utilise its production facilities for Reliance Life Sciences.

In its latest annual report, IPCL has said, "Since Reliance Life Sciences is engaged in the field of biotechnology research, it has been decided to utilise their expertise in setting up biotechnology-based production facilities at the corporation's site."

Reliance Life is setting up this facility in addition to a life sciences complex being built by the New Jersey-based Kvaerner, the global engineering and construction firm, at Thane, near Mumbai.

The complex is expected to house research and development laboratories and a greenhouse, and is likely to be completed by the end of this year.

The campus also includes a comprehensive genetic centre as part of its cell biology group, in addition to the embryonic stem cells research facility and the assisted-reproduction facility.

It was a preliminary step towards launching commercial operations for the company's cell biology initiatives.

Reliance Life, a privately held company, was incorporated in 2001 to carry out research and develop in medical, plant and industrial biotechnology.

It recently joined hands with Thyrocare Technologies, the world's largest thyroid-testing laboratory, to offer DNA technology-based genetic testing services across the country.

Reliance, with the National Centre for Biological Sciences, Bangalore, was recognised by the National Institute of Health of the US as one of the global agencies with a credible collection of stem cell lines.


Powered by



Article Tools

Email this Article

Printer-Friendly Format

Letter to the Editor




People Who Read This Also Read


Ambanis told to appear in court

Banks cutting govt stake

Blue Star rallies on mega dividend







HOME   
   NEWS   
   BUSINESS   
   CRICKET   
   SPORTS   
   MOVIES   
   NET GUIDE   
   SHOPPING   
   BLOGS  
   ASTROLOGY  
   MATCHMAKER  
© 2003 rediff.com India Limited. All Rights Reserved.